TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Kubator Therapeutics AB
Closing information (x1000 NOK)
Closing information | 2024/01 | 2023/01 | 2022/01 |
Turnover | 2,642 | 2,812 | 2,282 |
Financial expenses | 437 | 60 | 0 |
Earnings before taxes | 1,447 | 1,662 | 781 |
EBITDA | 1,747 | 1,624 | 738 |
Total assets | 5,194 | 4,160 | 3,159 |
Current assets | 3,568 | 2,486 | 1,637 |
Current liabilities | 2,123 | 1,402 | 1,780 |
Equity capital | 2,755 | 2,550 | 1,227 |
- share capital | 50 | 48 | 48 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2024/01 | 2023/01 | 2022/01 |
Solvency | 53.0% | 61.3% | 38.8% |
Turnover per employee | 2,642 | 2,812 | 2,282 |
Profit as a percentage of turnover | 54.8% | 59.1% | 34.2% |
Return on assets (ROA) | 36.3% | 41.4% | 24.7% |
Current ratio | 168.1% | 177.3% | 92.0% |
Return on equity (ROE) | 52.5% | 65.2% | 63.7% |
Change turnover | -306 | 516 | 702 |
Change turnover % | -10% | 22% | 44% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2024/01 | 2023/01 | 2022/01 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.